Intratumor and informatic heterogeneity influence meningioma molecular classification.

Harish N Vasudevan, Abrar Choudhury, Stephanie Hilz, Javier E Villanueva-Meyer, William C Chen, Calixto-Hope G Lucas, Steve E Braunstein, Nancy Ann Oberheim Bush, Nicholas Butowski, Melike Pekmezci, Michael W McDermott, Arie Perry, David A Solomon, Stephen T Magill, David R Raleigh
Author Information
  1. Harish N Vasudevan: Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA.
  2. Abrar Choudhury: Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA.
  3. Stephanie Hilz: Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.
  4. Javier E Villanueva-Meyer: Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, USA.
  5. William C Chen: Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA.
  6. Calixto-Hope G Lucas: Department of Pathology, University of California San Francisco, San Francisco, CA, USA.
  7. Steve E Braunstein: Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA.
  8. Nancy Ann Oberheim Bush: Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.
  9. Nicholas Butowski: Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.
  10. Melike Pekmezci: Department of Pathology, University of California San Francisco, San Francisco, CA, USA.
  11. Michael W McDermott: Miami Neuroscience Institute, Baptist Health, Miami, FL, USA.
  12. Arie Perry: Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.
  13. David A Solomon: Department of Pathology, University of California San Francisco, San Francisco, CA, USA.
  14. Stephen T Magill: Department of Neurological Surgery, Northwestern University, Chicago, IL, USA. stephen.magill@northwestern.edu.
  15. David R Raleigh: Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA. david.raleigh@ucsf.edu.

Abstract

No abstract text available.

References

  1. J Natl Cancer Inst. 2015 Dec 13;108(5): [PMID: 26668184]
  2. Neurol Res. 1999 Dec;21(8):721-6 [PMID: 10596379]
  3. Neuro Oncol. 2019 Jan 14;21(Suppl 1):i18-i31 [PMID: 30649489]
  4. Acta Neuropathol. 2019 Aug;138(2):295-308 [PMID: 31069492]
  5. Nature. 2021 Sep;597(7874):119-125 [PMID: 34433969]
  6. Neuro Oncol. 2019 Jul 11;21(7):901-910 [PMID: 31158293]
  7. J Neurooncol. 2019 Dec;145(3):449-459 [PMID: 31729637]
  8. Nat Commun. 2020 Sep 23;11(1):4803 [PMID: 32968068]
  9. Neuro Oncol. 2017 May 1;19(5):699-709 [PMID: 28453743]
  10. Neuro Oncol. 2004 Oct;6(4):290-9 [PMID: 15494096]
  11. Bioinformatics. 2018 Sep 15;34(18):3217-3219 [PMID: 29897414]
  12. J Clin Oncol. 2021 Dec 1;39(34):3839-3852 [PMID: 34618539]
  13. Cancer Discov. 2020 Nov;10(11):1722-1741 [PMID: 32703768]
  14. J Neurosurg Sci. 1996 Mar;40(1):17-23 [PMID: 8913957]
  15. Nucleic Acids Res. 2018 Nov 16;46(20):e123 [PMID: 30085201]
  16. Nat Commun. 2020 Jan 3;11(1):89 [PMID: 31900397]
  17. Nature. 2018 Mar 22;555(7697):524-528 [PMID: 29539641]
  18. Cell Rep. 2018 Mar 27;22(13):3672-3683 [PMID: 29590631]
  19. Lancet Oncol. 2017 May;18(5):682-694 [PMID: 28314689]
  20. Proc Natl Acad Sci U S A. 2019 Oct 22;116(43):21715-21726 [PMID: 31591222]
  21. J Mol Diagn. 2004 Nov;6(4):316-25 [PMID: 15507670]
  22. Oncotarget. 2017 Nov 24;8(65):109228-109237 [PMID: 29312603]
  23. Nat Genet. 2022 May;54(5):649-659 [PMID: 35534562]
  24. Acta Neuropathol. 2017 Mar;133(3):431-444 [PMID: 28130639]
  25. J Neurosurg. 2019 Oct 25;:1-10 [PMID: 31653806]
  26. Neuro Oncol. 2021 Aug 2;23(8):1231-1251 [PMID: 34185076]
  27. Neuro Oncol. 2022 May 4;24(5):796-808 [PMID: 34508644]
  28. Neuro Oncol. 2018 Nov 12;20(12):1584-1593 [PMID: 30010853]
  29. Bioinformatics. 2018 May 15;34(10):1642-1649 [PMID: 29325057]
  30. Neuro Oncol. 2021 May 5;23(5):783-794 [PMID: 33068421]

Grants

  1. T32 CA151022/NCI NIH HHS
  2. T32 GM007618/NIGMS NIH HHS
  3. F32 CA213944/NCI NIH HHS
  4. F30 CA246808/NCI NIH HHS
  5. R01 CA262311/NCI NIH HHS
  6. P50 CA097257/NCI NIH HHS
  7. DP5 OD021403/NIH HHS

MeSH Term

Biomarkers, Tumor
Genetic Heterogeneity
Humans
Informatics
Meningeal Neoplasms
Meningioma
Mutation

Chemicals

Biomarkers, Tumor

Word Cloud

Created with Highcharts 10.0.0Intratumorinformaticheterogeneityinfluencemeningiomamolecularclassification

Similar Articles

Cited By